Giorgio Bogani Selected Research

Drug Therapy (Chemotherapy)

2/2022	Eradication of Isolated Para-Aortic Nodal Recurrence in a Patient with an Advanced High Grade Serous Ovarian Carcinoma: Our Experience and Review of Literature.
1/2022	Clear cell carcinoma of the endometrium.
10/2021	Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.
3/2021	Patterns of failure after adjuvant "sandwich" chemo-radio-chemotherapy in locally advanced (stage III-IVA) endometrial cancer.
1/2021	Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
1/2021	Uterine serous carcinoma.
10/2020	From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?
1/2020	Role of adjuvant therapy in stage IIIC2 endometrial cancer.
1/2020	Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers.
1/2020	Immunotherapy for platinum-resistant ovarian cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giorgio Bogani Research Topics

Disease

33	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2022 - 10/2013
31	Neoplasms (Cancer) 12/2022 - 03/2011
24	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 07/2015
24	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2012
7	Carcinoma (Carcinomatosis) 01/2022 - 08/2013
7	Leiomyosarcoma 01/2020 - 04/2015
6	Sarcoma (Soft Tissue Sarcoma) 06/2018 - 02/2016
5	Neoplasm Metastasis (Metastasis) 02/2022 - 03/2016
5	Infections 10/2020 - 03/2017
4	Uterine Cervical Dysplasia 12/2022 - 01/2019
4	Ovarian Epithelial Carcinoma 01/2022 - 09/2014
4	Myoma 01/2017 - 09/2014
4	Pain (Aches) 12/2015 - 07/2014
3	COVID-19 01/2022 - 07/2020
3	Papillomavirus Infections 01/2021 - 03/2017
3	Melanoma (Melanoma, Malignant) 12/2020 - 01/2017
3	Postoperative Pain 12/2015 - 08/2010
2	Hypertension (High Blood Pressure) 01/2021 - 08/2009
2	Smooth Muscle Tumor 01/2018 - 05/2016
2	Lymphocele 07/2017 - 01/2012
2	Uterine Diseases (Endometrial Disease) 06/2015 - 01/2015
2	Pelvic Organ Prolapse 01/2015 - 07/2013
2	Pneumoperitoneum 09/2014 - 05/2014
2	Hemorrhage 07/2014 - 12/2011
2	Female Genital Diseases 09/2013 - 08/2010
1	Vascular System Injuries 02/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Lacerations 01/2022
1	Teratoma (Teratoid Tumor) 01/2021
1	Dysgerminoma 01/2021
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021
1	Margins of Excision 12/2020
1	Lymphatic Metastasis 09/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Peritoneal Neoplasms 01/2020
1	Lymphatic Diseases 11/2019
1	Cardiotoxicity 08/2019
1	Endometrial Hyperplasia 07/2019
1	Hyperplasia 07/2019

Drug/Important Bio-Agent (IBA)

7	PlatinumIBA 01/2022 - 06/2017
3	Papillomavirus Vaccines (HPV Vaccines)IBA 02/2022 - 02/2018
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	Bevacizumab (Avastin)FDA Link 10/2021 - 06/2018
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020 - 01/2015
3	Angiogenesis InhibitorsIBA 06/2018 - 06/2017
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	pembrolizumabIBA 01/2022 - 01/2021
2	lenvatinibIBA 01/2022 - 01/2021
2	VaccinesIBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 05/2018 - 08/2017
1	AlpelisibIBA 03/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	NivolumabIBA 01/2022
1	cabozantinibIBA 01/2022
1	TitaniumIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Biological ProductsIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Gemcitabine FDA Link 01/2020
1	Technetium (Technetium 99m)IBA 01/2020
1	AnthracyclinesIBA 01/2020
1	liposomal doxorubicin (Doxil)FDA Link 08/2019
1	1-dodecylpyridoxal (PLD)IBA 08/2019
1	Levonorgestrel (Plan B)FDA LinkGeneric 07/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Combined VaccinesIBA 09/2018

Therapy/Procedure

31	Hysterectomy 12/2022 - 08/2010
19	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2012
18	Drug Therapy (Chemotherapy) 02/2022 - 09/2014
16	Neoadjuvant Therapy 01/2020 - 08/2013
15	Minimally Invasive Surgical Procedures 08/2022 - 12/2011
13	Therapeutics 01/2022 - 08/2013
8	Morcellation 02/2018 - 12/2014
6	Operative Surgical Procedures 02/2022 - 02/2014
6	Cytoreduction Surgical Procedures 01/2019 - 09/2014
4	Operative Time 02/2022 - 07/2014
4	Radiotherapy 01/2021 - 12/2014
3	Laparotomy 02/2022 - 01/2017
3	Salpingo-oophorectomy 01/2022 - 10/2016
3	Immunotherapy 01/2022 - 01/2020
3	Adjuvant Chemotherapy 01/2021 - 11/2016
3	Conservative Treatment 01/2021 - 04/2014
3	Lasers (Laser) 12/2020 - 01/2018
3	Vaginal Hysterectomy 07/2017 - 08/2010
3	Blood Transfusion (Blood Transfusions) 01/2017 - 05/2013
3	Adjuvant Radiotherapy 12/2015 - 03/2011
2	Aftercare (After-Treatment) 01/2019 - 03/2017
2	Uterine Myomectomy 05/2016 - 09/2014
2	Length of Stay 12/2015 - 08/2010
2	Cesarean Section (Caesarean Section) 01/2015 - 08/2009
2	Ovariectomy (Oophorectomy) 10/2014 - 03/2013
1	Trachelectomy 12/2022
1	Secondary Prevention 10/2020
1	Electronic Nose 08/2020